As pharmaceutical supply chains evolve, with more direct-to-patient deliveries, temperature-sensitive medicines and specialist treatments in circulation, the demands placed on packaging are greater than ever. A solution that works well at one stage may not offer sufficient protection at another, leaving products vulnerable to temperature fluctuations, physical damage, compliance issues and security risks.
So, what are the biggest pharmaceutical packaging challenges facing modern supply chains, and how can businesses address them? In this guide, we explore six key challenges, from maintaining the cold chain and surviving transit to ensuring compliance, preventing tampering and improving sustainability. We also look at why taking a whole-journey approach to packaging design is essential for protecting products from manufacturer to patient.
A supply chain with more handoffs than ever
Traditionally, pharmaceutical products have followed a straightforward route from manufacturer to wholesaler and then pharmacy. However, modern supply chains are becoming more complex, with direct-to-patient deliveries, clinical trial shipments and specialist medicines such as biologics creating new distribution routes.
Each additional handoff introduces potential risks, from temperature fluctuations and physical damage to delays and handling errors. Pharmaceutical packaging must therefore do more than protect products during standard transit. It needs to maintain product integrity across different environments, transport methods and handling conditions, right through to the final recipient.